Fresenius Kabi unveils adenosine injection in prefilled syringesFresenius Kabi is the first company to offer adenosine in both vials and prefilled syringes. Endo launches authorized Proventil genericEndo’s Par Pharmaceutical is distributing the authorized generic of Merck's Proventil. FDA gives tentative nod for Perrigo’s generic Sernivo spray Betamethasone dipropionate had a market value of about $15 million for the 12 months ending February 2019, according to IQVIA. Sandoz launches generic Remodulin Sandoz will collaborate with RareGen to commercialize its generic Remodulin (treprostinil injection). ANI Pharmaceuticals launches 2 generics Methylphenidate hydrochloride extended-release tablets have a market value of roughly $505 million, and erythromycin ethylsuccinate for oral suspension has a market value of $16 million. Apotex reportedly considering a sale Apotex's business is valued at roughly $3 billion, according to a Bloomberg report. Armas Pharmaceuticals launches 2 generics Armas Pharmaceuticals is introducing generic Xeloda and Gleevec, which had a market value of roughly $108 million and $655 million, respectively. FDA issues REMS guidance to spur generic drug development The FDA has clarified several factors that determine whether a Risk Evaluation and Mitigation Strategy is required for a drug. CREATES Act passes House Committee The House Energy and Commerce Committee voted 51-0 to pass the CREATES Act of 2019. Alembic gets FDA's green light for generic Cialis Tadalafil tablets have a market value of $1.8 billion for the twelve months ending December 2018. First Previous 176 177 178 179 180 Next Last